tiprankstipranks
Diaceutics (GB:DXRX)
LSE:DXRX
UK Market

Diaceutics (DXRX) Income Statement

Compare
10 Followers

Diaceutics Income Statement

Last quarter (Q2 2024), Diaceutics's total revenue was £12.32M, an increase of 63.66% from the same quarter last year. In Q2, Diaceutics's net income was £-2.58M. See Diaceutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
£ 23.70M£ 19.50M£ 13.94M£ 12.70M£ 13.44M
Gross Profit
£ 19.71M£ 14.04M£ 10.57M£ 9.33M£ 10.31M
Operating Expenses
£ 22.72M£ 13.71M£ 10.25M£ 9.94M£ 8.19M
Depreciation and Amortization
£ 4.77M£ 3.01M£ 1.80M£ 809.00K£ 284.86K
EBITDA
£ 2.36M£ 3.61M£ 2.11M£ 178.00K£ 847.58K
Operating Income
£ -2.72M£ 331.00K£ 313.00K£ -610.00K£ 2.12M
Other Income/Expenses
£ 280.00K£ -97.00K£ -88.00K£ -72.00K£ -243.00K
Pretax Income
£ -2.44M£ 478.00K£ 293.00K£ -929.00K£ 340.32K
Net Income
£ -1.75M£ 724.00K£ 561.00K£ 263.00K£ 398.00K
Per Share Metrics
£ ―£ ―£ ―£ ―£ ―
Basic EPS
£ -0.02£ 0.01£ 0.01£ 0.00£ 0.01
Diluted EPS
£ -0.02£ 0.01£ 0.01£ 0.00£ 0.01
Weighted Average Shares Outstanding
84.23M 84.15M 83.94M 77.53M 64.07M
Weighted Average Shares Outstanding (Diluted)
84.23M 86.09M 84.94M 77.83M 64.17M
Currency in GBP

Diaceutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis